Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for pCO₂ and pO₂ Monitoring in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for pCO₂ and pO₂ Monitoring in Bioreactor Operations – V 2.0


Standard Operating Procedure for pCO₂ and pO₂ Monitoring in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/083/2025
Supersedes SOP/BS/083/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for monitoring partial pressure of carbon dioxide (pCO₂) and oxygen (pO₂) during bioreactor operations for biosimilar production, using inline sensors and off-line validation to ensure cell culture health and productivity.

2. Scope

This SOP applies to all bioreactor systems in upstream processing of biosimilars that utilize real-time pCO₂ and pO₂ monitoring via probes or external analyzers.

3. Responsibilities

  • Bioprocess Technicians: Monitor and log pCO₂ and pO₂ values routinely and escalate deviations.
  • Instrumentation Engineer: Calibrate and maintain gas sensors and analyzers.
  • QA Personnel: Review gas level trends and verify control actions.

4. Accountability

The Production Head is accountable for maintaining accurate pCO₂/pO₂ profiles during bioreactor culture and ensuring adherence to validated ranges.

5. Procedure

5.1 Sensor Setup and Calibration

  1. Ensure pCO₂ and pO₂ sensors are installed, sterilized, and connected to the controller or SCADA system.
  2. Calibrate sensors as per SOP/BS/082/2025 before each batch or after any probe replacement.
  3. Verify baseline and slope using certified gas standards (5% CO₂, 21% O₂).

5.2 Online Monitoring

  1. Start recording pCO₂ and pO₂ levels once inoculation is complete.
  2. Typical acceptable values:
    • pO₂: Maintain 30%–70% of air saturation
    • pCO₂: Maintain below 100 mmHg (approx. 13.3 kPa)
  3. Monitor trends continuously and log data every 2–4 hours in Annexure-1.
  4. Adjust agitation, aeration, or CO₂ gassing based on deviations.

5.3 Off-line Validation (if required)

  1. Collect 5 mL of culture fluid and transfer to blood gas analyzer under sterile conditions.
  2. Compare off-line readings with inline sensor output to validate accuracy.
  3. Document comparative data in Annexure-2.

5.4 Corrective Action

  1. If pCO₂ exceeds limits:
    • Increase headspace aeration or use alkaline base to counter acidification.
  2. If pO₂ drops:
    • Increase stirrer speed, sparger airflow, or add pure O₂ as needed.

5.5 Documentation

  1. All readings must be recorded in Gas Monitoring Log (Annexure-1).
  2. Any interventions or parameter changes must be authorized and recorded.

6. Abbreviations

  • pO₂: Partial Pressure of Oxygen
  • pCO₂: Partial Pressure of Carbon Dioxide
  • SCADA: Supervisory Control and Data Acquisition
  • QA: Quality Assurance

7. Documents

  1. Gas Monitoring Log – Annexure-1
  2. Off-line Validation Record – Annexure-2

8. References

  • USP <1046> – Cell Viability and Growth
  • ICH Q8 – Pharmaceutical Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Gas Monitoring Log

Date Time Batch No. pO₂ (%) pCO₂ (mmHg) Action Taken Operator
04/05/2025 14:00 BS-083-B01 54 87 Normal Rajesh Kumar

Annexure-2: Off-line Validation Record

Date Sample ID Inline pO₂ Offline pO₂ Inline pCO₂ Offline pCO₂ Remarks
04/05/2025 GAS-058 52% 53% 89 mmHg 88 mmHg Within limits

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Added off-line comparison section and CO₂ intervention strategy Process Enhancement
See also  Biosimilars: SOP for Inactivation of Used Culture Broth - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Dispensing Materials for Intradermal Injections – V 2.0
Next Post: BA-BE Studies: SOP for Use of LC-MS/MS in BA/BE Studies – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version